Literature DB >> 2472166

Assessment of bone marrow infiltration in B-cell non-Hodgkin's lymphoma (NHL).

E L Dorey1, S V Outram, A Holder, A Z Rohatiner, F E Cotter, M Deane, A G Stansfeld, T A Lister, M A Horton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2472166      PMCID： PMC2247209          DOI： 10.1038/bjc.1989.161

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  9 in total

1.  Lymphocyte subsets in normal bone marrow.

Authors:  P Clark; D E Normansell; D J Innes; C E Hess
Journal:  Blood       Date:  1986-06       Impact factor: 22.113

2.  Molecular analysis of the t(14;18) chromosomal translocation in malignant lymphomas.

Authors:  L M Weiss; R A Warnke; J Sklar; M L Cleary
Journal:  N Engl J Med       Date:  1987-11-05       Impact factor: 91.245

3.  Anti-B1 monoclonal antibody and complement treatment in autologous bone-marrow transplantation for relapsed B-cell non-Hodgkin's lymphoma.

Authors:  L M Nadler; T Takvorian; L Botnick; R C Bast; R Finberg; S Hellman; G P Canellos; S F Schlossman
Journal:  Lancet       Date:  1984-08-25       Impact factor: 79.321

4.  Characterization of a human B lymphocyte-specific antigen.

Authors:  P Stashenko; L M Nadler; R Hardy; S F Schlossman
Journal:  J Immunol       Date:  1980-10       Impact factor: 5.422

5.  Expression of human B cell-associated antigens on leukemias and lymphomas: a model of human B cell differentiation.

Authors:  K C Anderson; M P Bates; B L Slaughenhoupt; G S Pinkus; S F Schlossman; L M Nadler
Journal:  Blood       Date:  1984-06       Impact factor: 22.113

6.  Expression of cell surface markers after human B lymphocyte activation.

Authors:  P Stashenko; L M Nadler; R Hardy; S F Schlossman
Journal:  Proc Natl Acad Sci U S A       Date:  1981-06       Impact factor: 11.205

7.  Derivation of lymphoma cell lines from microscopically normal bone marrow in patients with undifferentiated lymphomas: evidence of occult bone marrow involvement.

Authors:  D Benjamin; I T Magrath; E C Douglass; L M Corash
Journal:  Blood       Date:  1983-05       Impact factor: 22.113

8.  Elimination of malignant clonogenic cells from human bone marrow using multiple monoclonal antibodies and complement.

Authors:  R C Bast; P De Fabritiis; J Lipton; R Gelber; C Maver; L Nadler; S Sallan; J Ritz
Journal:  Cancer Res       Date:  1985-02       Impact factor: 12.701

9.  Circulating lymphoma cells in patients with B & T non-Hodgkin's lymphoma detected by immunoglobulin and T-cell receptor gene rearrangement.

Authors:  M Brada; S Mizutani; H Molgaard; J P Sloane; J Treleaven; A Horwich; M J Peckham
Journal:  Br J Cancer       Date:  1987-08       Impact factor: 7.640
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.